Loading…
Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate
Background: The “International consensus statement on testing and reporting antineutrophil cytoplasmic antibodies (ANCA)” advocates screening by indirect immunofluorescence (IIF), but external quality assessment programmes often demonstrate different IIF patterns for a single serum. Aim: To determin...
Saved in:
Published in: | Journal of clinical pathology 2002-09, Vol.55 (9), p.680-683 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b508t-5ce6984cc3624f46e602bc07713729392bf509cfbb040df69edb7cca22be68233 |
---|---|
cites | |
container_end_page | 683 |
container_issue | 9 |
container_start_page | 680 |
container_title | Journal of clinical pathology |
container_volume | 55 |
creator | Pollock, W Clarke, K Gallagher, K Hall, J Luckhurst, E McEvoy, R Melny, J Neil, J Nikoloutsopoulos, A Thompson, T Trevisin, M Savige, J |
description | Background: The “International consensus statement on testing and reporting antineutrophil cytoplasmic antibodies (ANCA)” advocates screening by indirect immunofluorescence (IIF), but external quality assessment programmes often demonstrate different IIF patterns for a single serum. Aim: To determine whether the variation in IIF patterns can be attributed solely to errors in interpretation. Methods: This study compared the IIF patterns produced by four sera (two with cytoplasmic or C-ANCA; one with perinuclear or P-ANCA with myeloperoxidase (MPO) specificity; and one P-ANCA without MPO specificity) that were tested in 11 different laboratories. The sera were examined according to individual laboratory protocols at dilutions of 1/10 to 1/40 using P1 (n = 4), P2 (n = 2), P3 (n = 2), or in house (n=3) neutrophil preparations and conjugates from manufacturers C1 (n = 3), C2 (n = 1), C3 (n = 2), C4 (n = 1), C5 (n = 2), and C6 (n = 2). The IIF patterns were noted in each laboratory, the testing repeated, and the fluorescent patterns photographed and subsequently discussed at a meeting of the Australian ANCA study group. Results: All IIF patterns described in individual laboratories were confirmed on retesting and by the ANCA study group. Neutrophil substrates produced commercially or in house varied in their ability to demonstrate cytoplasmic granularity and interlobular accentuation, which distinguish between “C-ANCA” and “C-ANCA (atypical)”. All commercial and in house neutrophil substrates demonstrated neutrophil nuclear extension of P-ANCA fluorescence, which correlates with MPO specificity. However, eight assays (eight of 43) from eight laboratories resulted in IIF patterns different from those usually seen. One of these produced a C-ANCA (atypical) rather than a C-ANCA pattern. The other seven resulted in at least some cytoplasmic fluorescence when the consensus pattern was P-ANCA with (n = 4) or without (n = 3) MPO specificity. These assays used three different commercial and one in house neutrophil substrate, and six different conjugates, with anti-IgG, anti-(Fab)`2, anti-Ig (heavy and light chain), and anti-G, A, and M activity. Four of the seven assays tested on commercial substrates had used the manufacturer's conjugates. Conclusions: This study indicates that the variation in IIF patterns seen with ANCA positive sera tested in different laboratories does not necessarily result from errors in the interpretation of patterns and cannot be attributed sol |
doi_str_mv | 10.1136/jcp.55.9.680 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1769745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4023025561</sourcerecordid><originalsourceid>FETCH-LOGICAL-b508t-5ce6984cc3624f46e602bc07713729392bf509cfbb040df69edb7cca22be68233</originalsourceid><addsrcrecordid>eNp9kc2O0zAUhS0EYkphxxpFQvxJpNiOY8cbpKqiMFIZWAyInWU7TsclsYPtjOgb8Nh4aDUzsGBlWfe7R-fcA8BjBBcIVfTNTo-Lul7wBW3gHTBDhOGSIELvghmEGJWcEXoCHsS4gxBVDFX3wQnCiBPOmxn4dToMk_NdP_lgojYuFaNMyQQXizH4dtKmLdS-kC5ZZ6YU_Hhh-0Lvkx97GQer_4yUb62Jxcvl2Wr5qriUYV-0ZjSutW5beFfcWo2TiinIZPJiW2jvdtM2_x6Ce53so3l0fOfgy_rd-epDufn0_nS13JSqhk0qa20ob4jWFcWkI9RQiJWGLOdimFccq66GXHdKQQLbjnLTKqa1xFgZ2uCqmoO3B91xUoNprxIH2Ysx2CG7Fl5a8ffE2Qux9ZcCMZpPWWeB50eB4H9MJiYx2Hy4vpfO-CkKhiHGvCYZfPoPuPNTcDlc1moQQpQ0LFOvD5QOPsZgumsrCIqrgkUuWNS14CIXnPEnt-3fwMdGM_DsCMioZd8F6bSNN1zVMFjlQ8xBeeBsTObn9VyG74KyitXi7OtKbD6vP64RPBffMv_iwKth93-LvwG0fM5V</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781116487</pqid></control><display><type>article</type><title>Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate</title><source>PubMed Central</source><creator>Pollock, W ; Clarke, K ; Gallagher, K ; Hall, J ; Luckhurst, E ; McEvoy, R ; Melny, J ; Neil, J ; Nikoloutsopoulos, A ; Thompson, T ; Trevisin, M ; Savige, J</creator><creatorcontrib>Pollock, W ; Clarke, K ; Gallagher, K ; Hall, J ; Luckhurst, E ; McEvoy, R ; Melny, J ; Neil, J ; Nikoloutsopoulos, A ; Thompson, T ; Trevisin, M ; Savige, J</creatorcontrib><description>Background: The “International consensus statement on testing and reporting antineutrophil cytoplasmic antibodies (ANCA)” advocates screening by indirect immunofluorescence (IIF), but external quality assessment programmes often demonstrate different IIF patterns for a single serum. Aim: To determine whether the variation in IIF patterns can be attributed solely to errors in interpretation. Methods: This study compared the IIF patterns produced by four sera (two with cytoplasmic or C-ANCA; one with perinuclear or P-ANCA with myeloperoxidase (MPO) specificity; and one P-ANCA without MPO specificity) that were tested in 11 different laboratories. The sera were examined according to individual laboratory protocols at dilutions of 1/10 to 1/40 using P1 (n = 4), P2 (n = 2), P3 (n = 2), or in house (n=3) neutrophil preparations and conjugates from manufacturers C1 (n = 3), C2 (n = 1), C3 (n = 2), C4 (n = 1), C5 (n = 2), and C6 (n = 2). The IIF patterns were noted in each laboratory, the testing repeated, and the fluorescent patterns photographed and subsequently discussed at a meeting of the Australian ANCA study group. Results: All IIF patterns described in individual laboratories were confirmed on retesting and by the ANCA study group. Neutrophil substrates produced commercially or in house varied in their ability to demonstrate cytoplasmic granularity and interlobular accentuation, which distinguish between “C-ANCA” and “C-ANCA (atypical)”. All commercial and in house neutrophil substrates demonstrated neutrophil nuclear extension of P-ANCA fluorescence, which correlates with MPO specificity. However, eight assays (eight of 43) from eight laboratories resulted in IIF patterns different from those usually seen. One of these produced a C-ANCA (atypical) rather than a C-ANCA pattern. The other seven resulted in at least some cytoplasmic fluorescence when the consensus pattern was P-ANCA with (n = 4) or without (n = 3) MPO specificity. These assays used three different commercial and one in house neutrophil substrate, and six different conjugates, with anti-IgG, anti-(Fab)`2, anti-Ig (heavy and light chain), and anti-G, A, and M activity. Four of the seven assays tested on commercial substrates had used the manufacturer's conjugates. Conclusions: This study indicates that the variation in IIF patterns seen with ANCA positive sera tested in different laboratories does not necessarily result from errors in the interpretation of patterns and cannot be attributed solely to the use of a particular neutrophil substrate or conjugate, or to the use of substrate from one manufacturer and conjugate from another.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.55.9.680</identifier><identifier>PMID: 12194998</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Alcohol use ; ANCA ; Antibodies, Antineutrophil Cytoplasmic - blood ; antineutrophil cytoplasm antibodies ; antineutrophil cytoplasmic antibodies ; Biological and medical sciences ; C-ANCA ; Cell Nucleus - immunology ; Cytoplasm - immunology ; cytoplasmic antineutrophil cytoplasmic antibodies ; ELISA ; enzyme linked immunoassay ; Fluorescent Antibody Technique, Indirect - methods ; Fluorescent Antibody Technique, Indirect - standards ; Humans ; IIF ; Immunoglobulins ; indirect immunofluorescence ; Inflammatory bowel disease ; Investigative techniques, diagnostic techniques (general aspects) ; Laboratories - standards ; Medical sciences ; Microscopy ; Miscellaneous. Technology ; MPO ; myeloperoxidase ; Neutrophils ; Neutrophils - immunology ; Original ; P-ANCA ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; perinuclear antineutrophil cytoplasmic antibodies ; Peroxidase - immunology ; PR3 ; proteinase 3 ; Reproducibility of Results ; Testing laboratories ; vasculitis ; Wegener's granulomatosis</subject><ispartof>Journal of clinical pathology, 2002-09, Vol.55 (9), p.680-683</ispartof><rights>Copyright 2002 Journal of Clinical Pathology</rights><rights>2002 INIST-CNRS</rights><rights>Copyright: 2002 Copyright 2002 Journal of Clinical Pathology</rights><rights>Copyright © Copyright 2002 Journal of Clinical Pathology 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b508t-5ce6984cc3624f46e602bc07713729392bf509cfbb040df69edb7cca22be68233</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769745/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769745/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13870382$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12194998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pollock, W</creatorcontrib><creatorcontrib>Clarke, K</creatorcontrib><creatorcontrib>Gallagher, K</creatorcontrib><creatorcontrib>Hall, J</creatorcontrib><creatorcontrib>Luckhurst, E</creatorcontrib><creatorcontrib>McEvoy, R</creatorcontrib><creatorcontrib>Melny, J</creatorcontrib><creatorcontrib>Neil, J</creatorcontrib><creatorcontrib>Nikoloutsopoulos, A</creatorcontrib><creatorcontrib>Thompson, T</creatorcontrib><creatorcontrib>Trevisin, M</creatorcontrib><creatorcontrib>Savige, J</creatorcontrib><title>Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>Background: The “International consensus statement on testing and reporting antineutrophil cytoplasmic antibodies (ANCA)” advocates screening by indirect immunofluorescence (IIF), but external quality assessment programmes often demonstrate different IIF patterns for a single serum. Aim: To determine whether the variation in IIF patterns can be attributed solely to errors in interpretation. Methods: This study compared the IIF patterns produced by four sera (two with cytoplasmic or C-ANCA; one with perinuclear or P-ANCA with myeloperoxidase (MPO) specificity; and one P-ANCA without MPO specificity) that were tested in 11 different laboratories. The sera were examined according to individual laboratory protocols at dilutions of 1/10 to 1/40 using P1 (n = 4), P2 (n = 2), P3 (n = 2), or in house (n=3) neutrophil preparations and conjugates from manufacturers C1 (n = 3), C2 (n = 1), C3 (n = 2), C4 (n = 1), C5 (n = 2), and C6 (n = 2). The IIF patterns were noted in each laboratory, the testing repeated, and the fluorescent patterns photographed and subsequently discussed at a meeting of the Australian ANCA study group. Results: All IIF patterns described in individual laboratories were confirmed on retesting and by the ANCA study group. Neutrophil substrates produced commercially or in house varied in their ability to demonstrate cytoplasmic granularity and interlobular accentuation, which distinguish between “C-ANCA” and “C-ANCA (atypical)”. All commercial and in house neutrophil substrates demonstrated neutrophil nuclear extension of P-ANCA fluorescence, which correlates with MPO specificity. However, eight assays (eight of 43) from eight laboratories resulted in IIF patterns different from those usually seen. One of these produced a C-ANCA (atypical) rather than a C-ANCA pattern. The other seven resulted in at least some cytoplasmic fluorescence when the consensus pattern was P-ANCA with (n = 4) or without (n = 3) MPO specificity. These assays used three different commercial and one in house neutrophil substrate, and six different conjugates, with anti-IgG, anti-(Fab)`2, anti-Ig (heavy and light chain), and anti-G, A, and M activity. Four of the seven assays tested on commercial substrates had used the manufacturer's conjugates. Conclusions: This study indicates that the variation in IIF patterns seen with ANCA positive sera tested in different laboratories does not necessarily result from errors in the interpretation of patterns and cannot be attributed solely to the use of a particular neutrophil substrate or conjugate, or to the use of substrate from one manufacturer and conjugate from another.</description><subject>Alcohol use</subject><subject>ANCA</subject><subject>Antibodies, Antineutrophil Cytoplasmic - blood</subject><subject>antineutrophil cytoplasm antibodies</subject><subject>antineutrophil cytoplasmic antibodies</subject><subject>Biological and medical sciences</subject><subject>C-ANCA</subject><subject>Cell Nucleus - immunology</subject><subject>Cytoplasm - immunology</subject><subject>cytoplasmic antineutrophil cytoplasmic antibodies</subject><subject>ELISA</subject><subject>enzyme linked immunoassay</subject><subject>Fluorescent Antibody Technique, Indirect - methods</subject><subject>Fluorescent Antibody Technique, Indirect - standards</subject><subject>Humans</subject><subject>IIF</subject><subject>Immunoglobulins</subject><subject>indirect immunofluorescence</subject><subject>Inflammatory bowel disease</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Laboratories - standards</subject><subject>Medical sciences</subject><subject>Microscopy</subject><subject>Miscellaneous. Technology</subject><subject>MPO</subject><subject>myeloperoxidase</subject><subject>Neutrophils</subject><subject>Neutrophils - immunology</subject><subject>Original</subject><subject>P-ANCA</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>perinuclear antineutrophil cytoplasmic antibodies</subject><subject>Peroxidase - immunology</subject><subject>PR3</subject><subject>proteinase 3</subject><subject>Reproducibility of Results</subject><subject>Testing laboratories</subject><subject>vasculitis</subject><subject>Wegener's granulomatosis</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kc2O0zAUhS0EYkphxxpFQvxJpNiOY8cbpKqiMFIZWAyInWU7TsclsYPtjOgb8Nh4aDUzsGBlWfe7R-fcA8BjBBcIVfTNTo-Lul7wBW3gHTBDhOGSIELvghmEGJWcEXoCHsS4gxBVDFX3wQnCiBPOmxn4dToMk_NdP_lgojYuFaNMyQQXizH4dtKmLdS-kC5ZZ6YU_Hhh-0Lvkx97GQer_4yUb62Jxcvl2Wr5qriUYV-0ZjSutW5beFfcWo2TiinIZPJiW2jvdtM2_x6Ce53so3l0fOfgy_rd-epDufn0_nS13JSqhk0qa20ob4jWFcWkI9RQiJWGLOdimFccq66GXHdKQQLbjnLTKqa1xFgZ2uCqmoO3B91xUoNprxIH2Ysx2CG7Fl5a8ffE2Qux9ZcCMZpPWWeB50eB4H9MJiYx2Hy4vpfO-CkKhiHGvCYZfPoPuPNTcDlc1moQQpQ0LFOvD5QOPsZgumsrCIqrgkUuWNS14CIXnPEnt-3fwMdGM_DsCMioZd8F6bSNN1zVMFjlQ8xBeeBsTObn9VyG74KyitXi7OtKbD6vP64RPBffMv_iwKth93-LvwG0fM5V</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Pollock, W</creator><creator>Clarke, K</creator><creator>Gallagher, K</creator><creator>Hall, J</creator><creator>Luckhurst, E</creator><creator>McEvoy, R</creator><creator>Melny, J</creator><creator>Neil, J</creator><creator>Nikoloutsopoulos, A</creator><creator>Thompson, T</creator><creator>Trevisin, M</creator><creator>Savige, J</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>Copyright 2002 Journal of Clinical Pathology</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020901</creationdate><title>Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate</title><author>Pollock, W ; Clarke, K ; Gallagher, K ; Hall, J ; Luckhurst, E ; McEvoy, R ; Melny, J ; Neil, J ; Nikoloutsopoulos, A ; Thompson, T ; Trevisin, M ; Savige, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b508t-5ce6984cc3624f46e602bc07713729392bf509cfbb040df69edb7cca22be68233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Alcohol use</topic><topic>ANCA</topic><topic>Antibodies, Antineutrophil Cytoplasmic - blood</topic><topic>antineutrophil cytoplasm antibodies</topic><topic>antineutrophil cytoplasmic antibodies</topic><topic>Biological and medical sciences</topic><topic>C-ANCA</topic><topic>Cell Nucleus - immunology</topic><topic>Cytoplasm - immunology</topic><topic>cytoplasmic antineutrophil cytoplasmic antibodies</topic><topic>ELISA</topic><topic>enzyme linked immunoassay</topic><topic>Fluorescent Antibody Technique, Indirect - methods</topic><topic>Fluorescent Antibody Technique, Indirect - standards</topic><topic>Humans</topic><topic>IIF</topic><topic>Immunoglobulins</topic><topic>indirect immunofluorescence</topic><topic>Inflammatory bowel disease</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Laboratories - standards</topic><topic>Medical sciences</topic><topic>Microscopy</topic><topic>Miscellaneous. Technology</topic><topic>MPO</topic><topic>myeloperoxidase</topic><topic>Neutrophils</topic><topic>Neutrophils - immunology</topic><topic>Original</topic><topic>P-ANCA</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>perinuclear antineutrophil cytoplasmic antibodies</topic><topic>Peroxidase - immunology</topic><topic>PR3</topic><topic>proteinase 3</topic><topic>Reproducibility of Results</topic><topic>Testing laboratories</topic><topic>vasculitis</topic><topic>Wegener's granulomatosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pollock, W</creatorcontrib><creatorcontrib>Clarke, K</creatorcontrib><creatorcontrib>Gallagher, K</creatorcontrib><creatorcontrib>Hall, J</creatorcontrib><creatorcontrib>Luckhurst, E</creatorcontrib><creatorcontrib>McEvoy, R</creatorcontrib><creatorcontrib>Melny, J</creatorcontrib><creatorcontrib>Neil, J</creatorcontrib><creatorcontrib>Nikoloutsopoulos, A</creatorcontrib><creatorcontrib>Thompson, T</creatorcontrib><creatorcontrib>Trevisin, M</creatorcontrib><creatorcontrib>Savige, J</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pollock, W</au><au>Clarke, K</au><au>Gallagher, K</au><au>Hall, J</au><au>Luckhurst, E</au><au>McEvoy, R</au><au>Melny, J</au><au>Neil, J</au><au>Nikoloutsopoulos, A</au><au>Thompson, T</au><au>Trevisin, M</au><au>Savige, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>55</volume><issue>9</issue><spage>680</spage><epage>683</epage><pages>680-683</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>Background: The “International consensus statement on testing and reporting antineutrophil cytoplasmic antibodies (ANCA)” advocates screening by indirect immunofluorescence (IIF), but external quality assessment programmes often demonstrate different IIF patterns for a single serum. Aim: To determine whether the variation in IIF patterns can be attributed solely to errors in interpretation. Methods: This study compared the IIF patterns produced by four sera (two with cytoplasmic or C-ANCA; one with perinuclear or P-ANCA with myeloperoxidase (MPO) specificity; and one P-ANCA without MPO specificity) that were tested in 11 different laboratories. The sera were examined according to individual laboratory protocols at dilutions of 1/10 to 1/40 using P1 (n = 4), P2 (n = 2), P3 (n = 2), or in house (n=3) neutrophil preparations and conjugates from manufacturers C1 (n = 3), C2 (n = 1), C3 (n = 2), C4 (n = 1), C5 (n = 2), and C6 (n = 2). The IIF patterns were noted in each laboratory, the testing repeated, and the fluorescent patterns photographed and subsequently discussed at a meeting of the Australian ANCA study group. Results: All IIF patterns described in individual laboratories were confirmed on retesting and by the ANCA study group. Neutrophil substrates produced commercially or in house varied in their ability to demonstrate cytoplasmic granularity and interlobular accentuation, which distinguish between “C-ANCA” and “C-ANCA (atypical)”. All commercial and in house neutrophil substrates demonstrated neutrophil nuclear extension of P-ANCA fluorescence, which correlates with MPO specificity. However, eight assays (eight of 43) from eight laboratories resulted in IIF patterns different from those usually seen. One of these produced a C-ANCA (atypical) rather than a C-ANCA pattern. The other seven resulted in at least some cytoplasmic fluorescence when the consensus pattern was P-ANCA with (n = 4) or without (n = 3) MPO specificity. These assays used three different commercial and one in house neutrophil substrate, and six different conjugates, with anti-IgG, anti-(Fab)`2, anti-Ig (heavy and light chain), and anti-G, A, and M activity. Four of the seven assays tested on commercial substrates had used the manufacturer's conjugates. Conclusions: This study indicates that the variation in IIF patterns seen with ANCA positive sera tested in different laboratories does not necessarily result from errors in the interpretation of patterns and cannot be attributed solely to the use of a particular neutrophil substrate or conjugate, or to the use of substrate from one manufacturer and conjugate from another.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>12194998</pmid><doi>10.1136/jcp.55.9.680</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9746 |
ispartof | Journal of clinical pathology, 2002-09, Vol.55 (9), p.680-683 |
issn | 0021-9746 1472-4146 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1769745 |
source | PubMed Central |
subjects | Alcohol use ANCA Antibodies, Antineutrophil Cytoplasmic - blood antineutrophil cytoplasm antibodies antineutrophil cytoplasmic antibodies Biological and medical sciences C-ANCA Cell Nucleus - immunology Cytoplasm - immunology cytoplasmic antineutrophil cytoplasmic antibodies ELISA enzyme linked immunoassay Fluorescent Antibody Technique, Indirect - methods Fluorescent Antibody Technique, Indirect - standards Humans IIF Immunoglobulins indirect immunofluorescence Inflammatory bowel disease Investigative techniques, diagnostic techniques (general aspects) Laboratories - standards Medical sciences Microscopy Miscellaneous. Technology MPO myeloperoxidase Neutrophils Neutrophils - immunology Original P-ANCA Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques perinuclear antineutrophil cytoplasmic antibodies Peroxidase - immunology PR3 proteinase 3 Reproducibility of Results Testing laboratories vasculitis Wegener's granulomatosis |
title | Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A49%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunofluorescent%20patterns%20produced%20by%20antineutrophil%20cytoplasmic%20antibodies%20(ANCA)%20vary%20depending%20on%20neutrophil%20substrate%20and%20conjugate&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=Pollock,%20W&rft.date=2002-09-01&rft.volume=55&rft.issue=9&rft.spage=680&rft.epage=683&rft.pages=680-683&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.55.9.680&rft_dat=%3Cproquest_pubme%3E4023025561%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b508t-5ce6984cc3624f46e602bc07713729392bf509cfbb040df69edb7cca22be68233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781116487&rft_id=info:pmid/12194998&rfr_iscdi=true |